Left atrial occlusion in intracerebral hemorrhage with atrial fibrillation,herpes zoster,and stroke,improving stroke outcomes in China,and Cerebrolysin as a treatment for acute stroke
Restricted accessEditorialFirst published online October, 2025
Left atrial occlusion in intracerebral hemorrhage with atrial fibrillation,herpes zoster,and stroke,improving stroke outcomes in China,and Cerebrolysin as a treatment for acute stroke
SposatoLACameronACJohansenMC, et al. Ischemic stroke prevention in patients with atrial fibrillation and a recent ischemic stroke, TIA, or intracranial hemorrhage: a World Stroke Organization (WSO) scientific statement. Int J Stroke2025; 20: 385–400.
2.
CordonnierCKlijnCSmithEE, et al. Diagnosis and management of cerebral amyloid angiopathy: a scientific statement from the International CAA Association and the World Stroke Organization. Int J Stroke2025; 20: 949–967.
3.
SchwarzGBanerjeeGHostettlerIC, et al. MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage. Int J Stroke2023; 18: 85–94.
4.
Van der ZwetRKoemansEAVoigtS, et al. Sensitivity of the Boston criteria version 2.0 in Dutch-type hereditary cerebral amyloid angiopathy. Int J Stroke2024; 19: 942–946.
5.
MavridisTArchontakis-BarakakisPChlorogiannisDDCharidimouA.Left atrial appendage occlusion in patients with atrial fibrillation and previous Intracranial Hemorrhage or Cerebral Amyloid Angiopathy: a systematic review and meta-analysis. Int J Stroke2025; 20: 1049–1059.
6.
NannoniSde GrootRBellSMarkusHS.Stroke in COVID-19: a systematic review and meta-analysis. Int J Stroke2021; 16: 137–149.
7.
SouthKMcCullochLMcCollBWElkindMSAllanSMSmithCJ.Preceding infection and risk of stroke: an old concept revived by the COVID-19 pandemic. Int J Stroke2020; 15: 722–732.
8.
GiannelosNCurranDNguyenCKagiaCVroomNVrolingH.The incidence of herpes zoster complications: a systematic literature review. Infect Dis Ther2024; 13: 1461–1486.
9.
NagelMA.Varicella zoster virus vasculopathy: clinical features and pathogenesis. J Neurovirol2014; 20: 157–163.
10.
YahavANaftaliJRyanD, et al. Association between herpes zoster infection and the risk of stroke: a population-based nested case–control study. Int J Stroke2025; 20: 1081–1089.
11.
YahavARyanDNaftaliJ, et al. Association between live herpes-zoster vaccine and stroke risk: a population-based nested case-control study. Int J Stroke. Epub ahead of print 6 September 2025. DOI: 10.1177/17474930251380184.
12.
TaquetMDerconQToddJAHarrisonPJ.The recombinant shingles vaccine is associated with lower risk of dementia. Nat Med2024; 30: 2777–2781.
13.
AnXWangBGeX, et al. Effectiveness of external ventricular drainage versus lumbar drainage in aneurysmal subarachnoid hemorrhage: a propensity-matched multicenter study. Int J Stroke2025; 20: 1071–1080.
ZhaoYHuaXRenX, et al. Increasing burden of stroke in China: a systematic review and meta-analysis of prevalence, incidence, mortality, and case fatality. Int J Stroke2023; 18: 259–267.
16.
ZhuZKJiangYYYangX, et al. Clinical characteristics, in-hospital management, and outcomes among patients hospitalized for acute ischemic stroke in rural versus urban hospitals in China: a nationwide hospital-based study. Int J Stroke2025; 20: 53–63.
17.
GuHQWangCJZhangXM, et al. Ten-year trends in sex differences in cardiovascular risk factors, in-hospital management, and outcomes of ischemic stroke in China: analyses of a nationwide serial cross-sectional survey from 2005 to 2015. Int J Stroke2023; 18: 821–828.
18.
LiuYLuoXXiangH, et al. Nationwide analysis of routine clinical practices in the management of acute ischemic stroke patients in China. Int J Stroke2025; 20: 1102–113.
19.
JiangQWangMLiuT, et al. Decade trends in risk factors, treatments, and prognosis of minor ischemic stroke and TIA in China. Int J Stroke2025; 20: 1090–1101.
20.
VoskoMRSanakDDoY, et al. CREGS-2—a multinational, high-quality comparative effectiveness study of Cerebrolysin in moderate acute ischemic stroke. Int J Stroke2025; 20: 1060–1070.
21.
MuresanuDFHeissWDHoembergV, et al. Cerebrolysin and Recovery After Stroke (CARS): a randomized, placebo-controlled, double-blind, multicenter trial. Stroke2016; 47: 151–159.
